Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma

Affiliations

Jean-Sébastien Claveau: Division of Hematology, Oncology and Transplantation, Department of Medicine, Maisonneuve-Rosemont Hospital, Université de Montréal
Sophie Savary Bélanger: Division of Hematology, Oncology and Transplantation, Department of Medicine, Maisonneuve-Rosemont Hospital, Université de Montréal
Imran Ahmad: Division of Hematology, Oncology and Transplantation, Department of Medicine, Maisonneuve-Rosemont Hospital, Université de Montréal
Jean-Sébastien Delisle: Division of Hematology, Oncology and Transplantation, Department of Medicine, Maisonneuve-Rosemont Hospital, Université de Montréal
Vincent De Guire: Department of Biochemistry, Maisonneuve-Rosemont Hospital, Université de Montréal
Jean Roy: Division of Hematology, Oncology and Transplantation, Department of Medicine, Maisonneuve-Rosemont Hospital, Université de Montréal
Richard LeBlanc: Division of Hematology, Oncology and Transplantation, Department of Medicine, Maisonneuve-Rosemont Hospital, Université de Montréal

Abstract

No abstracts available.

ISSN: 2044-5385 (Online)
Publisher: Nature Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.nature.com/bcj/index.html